Roche Molecular Systems this week unveiled the blueprint for its future molecular diagnostics strategy, providing attendees of the EuroMedLab conference in Milan, Italy, with a preview of its next two large-scale MDx systems.

Specifically, Roche introduced the Cobas 6800 and Cobas 8800 — essentially high- and very-high-throughput versions of the company's Cobas 4800 platform, which is already commercially available along with several US Food and Drug Administration-approved molecular assays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.